Internal Medicine, Gastroenterology · Denver, CO
NPI
1902850811
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
6
Medicare group memberships
Hospitals
4
Hospital affiliations
1960 Ogden St, Suite 220
Denver, CO, 80218
Phone (303) 861-0808
Groups this clinician bills Medicare through
Medicare paid, 2024
$92K
2,251 services
Medicare patients, 2024
328
Average age 73
Drug cost, 2024
$311K
924 prescriptions
Company payments, 2025
$1,173
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Thomas Trouillot was code 45380 (lower gi endoscopy - other), 84 times for 84 patients. In total Thomas Trouillot billed 2,251 services in 26 codes, and Medicare paid $92K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-04-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 45380 Lower GI Endoscopy - Other | Facility | 84 | 84 | $132.89 | $11K |
| 99214 Office E&M - Established | Office | 72 | 59 | $99.79 | $7,185 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 61 | 61 | $176.86 | $11K |
| 45385 Colonoscopy - Lesion Removal | Facility | 55 | 55 | $205.14 | $11K |
| 99204 Office E&M - New | Office | 42 | 42 | $119.94 | $5,038 |
| 43239 Upper GI Endoscopy | Facility | 35 | 35 | $65.58 | $2,295 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 17 | 17 | $179.25 | $3,047 |
| 99215 Office E&M - Established | Office | 12 | 12 | $144.15 | $1,730 |
By year: 2022 $53K for 548 services; 2023 $62K for 742 services; 2024 $92K for 2,251 services.
Medicare prescription drug claims, 2024
In 2024, the drug Thomas Trouillot prescribed most often to Medicare patients was Pantoprazole Sodium, with 224 prescriptions and refills. In total Thomas Trouillot wrote 924 Medicare prescriptions that cost $311K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 224 | 458 | 63 | $3,664 |
| Omeprazole Generic | 138 | 333 | 47 | $2,712 |
| Suflave Peg 3350/Sod Sulf,chlr/Pot/Mag | 88 | 88 | 88 | $11K |
| Azathioprine Generic | 76 | 184 | 17 | $4,114 |
| Mesalamine Generic | 53 | 118 | 13 | $18K |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 40 | 40 | 40 | $616 |
| Ursodiol Generic | 28 | 54 | Under 11 | $6,829 |
| Sucralfate Generic | 27 | 42 | Under 11 | $2,385 |
| Prednisone Generic | 26 | 41 | Under 11 | $216 |
| Peg-3350 And Electrolytes Peg3350/Sod Sulf,bicarb,cl/Kcl | 26 | 26 | 25 | $410 |
| Sulfasalazine Generic | 24 | 60 | Under 11 | $955 |
| Balsalazide Disodium Generic | 16 | 43 | Under 11 | $3,994 |
| Humira Pen Adalimumab | 14 | 14 | Under 11 | $90K |
| Famotidine Generic | 14 | 26 | Under 11 | $335 |
| Nortriptyline Hcl Generic | 12 | 14 | Under 11 | $56 |
Brand drugs: 193 claims; generic drugs: 731 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Thomas Trouillot $1,173 ($1,173 in general payments such as food, travel and fees) from 16 companies. The largest payer was Abbvie Inc. with $238.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 15 | $238 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 8 | $237 |
| Janssen Biotech, Inc. JNJ | 6 | $146 |
| Gilead Sciences, Inc. GILD | 4 | $84.64 |
| Lilly USA, LLC LLY | 4 | $78.97 |
| Genzyme Corporation SNY | 3 | $72.87 |
| Regeneron Healthcare Solutions, Inc. REGN | 3 | $61.84 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 2 | $47.08 |
| Madrigal Pharmaceuticals MDGL | 2 | $40.02 |
| Intercept Pharmaceuticals, Inc. | 2 | $33.27 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.